Commission and Commissioner Public Statements and Letters

Concurring Statement of Commissioner Rebecca Kelly Slaughter in the Matter of Shop Tutors, Inc. d/b/a LendEDU (133.22 KB)

Concurring Statement of Commissioner Rohit Chopra in Federal Trade Commission; and State of New York v. Vyera Pharmaceuticals, LLC; Phoenixus AG; Martin Shkreli; and Kevin Mulleady

Federal Trade Commission; and State of New York v. Vyera Pharmaceuticals, LLC; Phoenixus AG; Martin Shkreli; and Kevin Mulleady

Date: January 27, 2020

By:

Concurring Statement of Commissioner Rohit Chopra in Federal Trade Commission; and State of New York v. Vyera Pharmaceuticals, LLC; Phoenixus AG; Martin Shkreli; and Kevin Mulleady (140.28 KB)

Concurring Statement of Commissioner Rebecca Kelly Slaughter in Federal Trade Commission; and State of New York v. Vyera Pharmaceuticals, LLC; Phoenixus AG; Martin Shkreli; and Kevin Mulleady

Federal Trade Commission; and State of New York v. Vyera Pharmaceuticals, LLC; Phoenixus AG; Martin Shkreli; and Kevin Mulleady

Date: January 27, 2020

By:

Concurring Statement of Commissioner Rebecca Kelly Slaughter in Federal Trade Commission; and State of New York v. Vyera Pharmaceuticals, LLC; Phoenixus AG; Martin Shkreli; and Kevin Mulleady (32.62 KB)

Related Release:

Remarks of Commissioner Rebecca Kelly Slaughter on Algorithms and Economic Justice

UCLA School of Law

Date: January 24, 2020

By:

Remarks of Commissioner Rebecca Kelly Slaughter on Algorithms and Economic Justice (133.24 KB)

Concurring Statement of Commissioner Christine S. Wilson Concerning the Publication of FTC-DOJ Draft Vertical Merger Guidelines for Public Comment

Date: January 10, 2020

Matter Number:

P810034

By:

Concurring Statement of Commissioner Christine S. Wilson Concerning the Publication of FTC-DOJ Draft Vertical Merger Guidelines for Public Comment (45.62 KB)

Statement of Rebecca Kelly Slaughter on the FTC-DOJ Draft Vertical Merger Guidelines

Date: January 10, 2020

Matter Number:

P810034

By:

Statement of Commissioner Rebecca Kelly Slaughter on the FTC-DOJ Draft Vertical Merger Guidelines (298.47 KB)

Statement of Commissioner Rohit Chopra Regarding the Request for Comment on Vertical Merger Guidelines

Date: January 10, 2020

Matter Number:

P810034

By:

Statement of Commissioner Rohit Chopra Regarding the Request for Comment on Vertical Merger Guidelines (79.39 KB)

Statement of the Federal Trade Commission in the matter of Roche Holding/Spark Therapeutics

In the matter of Roche Holding/Spark Therapeutics

Date: December 16, 2019

Matter Number:

191 0086

By:

Joseph J. Simons;

Noah Joshua Phillips;

Rohit Chopra;

Rebecca Kelly Slaughter;

Statement of the Federal Trade Commission in the matter of Roche Holding/Spark Therapeutics (213.41 KB)

Concurring Statement of Commissioner Rebecca Kelly Slaughter In the Matter of the University of Phoenix, Inc.

Washington, D.C.

Date: December 10, 2019

Matter Number:

152 3231

By:

Concurring Statement of Commissioner Rebecca Kelly Slaughter In the Matter of the University of Phoenix, Inc. (407.62 KB)

Statement of Commissioner Rohit Chopra In the Matter of the University of Phoenix, Inc.

Washington, D.C.

Date: December 10, 2019

Matter Number:

152 3231

By:

Statement of Commissioner Rohit Chopra In the Matter of the University of Phoenix, Inc. (549.15 KB)

Comment of Commissioner Rebecca Kelly Slaughter on the Federal Energy Regulatory Commission’s Notice of Proposed Rulemaking regarding sections 201 and 210 of the Public Utilities Regulatory Policy Act

Washington, D.C.

Date: November 26, 2019

By:

Comment of Commissioner Rebecca Kelly Slaughter on the Federal Energy Regulatory Commission (228.43 KB)

Statement of Commissioner Christine S. Wilson In the Matter of Bristol-Myers Squibb Company and Celgene Corporation

Washington, D.C.

Date: November 15, 2019

Matter Number:

191 0061

Docket Number:

C-4690

By:

Statement of Commissioner Christine S. Wilson (58.08 KB)

Dissenting Statement of Commissioner Rebecca Kelly Slaughter In the Matter of Bristol-Myers Squibb Company and Celgene Corporation

Washington, D.C.

Date: November 15, 2019

Matter Number:

191 0061

Docket Number:

C-4690

By:

Dissenting Statement of Commissioner Rebecca Kelly Slaughter In the Matter of Bristol-Myers Squibb Company and Celgene Corporation (40.74 KB)

Statement of Commissioner Noah Joshua Phillips In the Matter of Bristol-Myers Squibb Company and Celgene Corporation

Washington, D.C.

Date: November 15, 2019

Matter Number:

191 0061

Docket Number:

C-4690

By:

Noah Joshua Phillips

Statement of Commissioner Noah Joshua Phillips In the Matter of Bristol-Myers Squibb Company and Celgene Corporation (55.17 KB)

Dissenting Statement of Commissioner Rohit Chopra In the Matter of Bristol-Myers Squibb Company and Celgene Corporation

Washington, D.C.

Date: November 15, 2019

Matter Number:

191 0061

Docket Number:

C-4690

By:

Dissenting Statement of Commissioner Rohit Chopra In the Matter of Bristol-Myers Squibb Company and Celgene Corporation (55.52 KB)

Concurring Statement of Commissioner Christine S. Wilson In the Matter of InfoTrax Systems, L.C.

In the Matter of InfoTrax Systems, L.C.

Date: November 12, 2019

Matter Number:

162 3130

By:

Concurring Statement of Commissioner Christine S. Wilson In the Matter of InfoTrax Systems, L.C. (32 KB)

Comment of Commissioner Rohit Chopra on the Federal Reserve Proposal to Develop Round-the-Clock, Real-Time Payments System FedNow Service

Date: November 7, 2019

By:

Comment of Commissioner Rohit Chopra on the Federal Reserve Proposal to Develop Round-the-Clock, Real-Time Payments System FedNow Service (142.88 KB)

Statement of Commissioner Rohit Chopra In the Matter of AT&T Mobility, LLC

Date: November 5, 2019

By:

Statement of Commissioner Rohit Chopra In the Matter of AT&T Mobility, LLC (94.62 KB)

Dissenting Statement of Commissioner Rohit Chopra In the Matter of Your Therapy Source, Neeraj Jindal and Sheri Yarbray

Date: October 31, 2019

By:

Dissenting Statement of Commissioner Rohit Chopra In the Matter of Your Therapy Source, Neeraj Jindal and Sheri Yarbray (79.34 KB)

Statement of Federal Trade Commission In the Matter of Your Therapy Source, Neeraj Jindal and Sheri Yarbray

Date: October 31, 2019

By:

Joseph J. Simons;

Noah Joshua Phillips;